Kenneth M. Comess

Kenneth M. Comess

Auto-generated profile, based on publicly available information

Kenneth M. Comess

Research & Development, AbbVie, 1 North Waukegan Road, North Chicago, Illinois 60064, United States

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JDJustin D. Dietrich
Justin D. Dietrich
KLKenton L. Longenecker
Kenton L. Longenecker
NWNoel S. Wilson
Noel S. Wilson
CGChristian Goess
Christian Goess
SPSanjay C. Panchal
Sanjay C. Panchal
CSChaohong Sun
Chaohong Sun

1 October 2001 in SLAS Discovery
Verified
Journal Article
Open access
MSMark E. Schurdak
Mark E. Schurdak
MVMartin J. Voorbach
Martin J. Voorbach
LGLan Gao
Lan Gao
XCXueheng Cheng
Xueheng Cheng
KCKenneth M. Comess
Kenneth M. Comess
BBBruce A. Beutel
Bruce A. Beutel
Gel permeation methods have been commonly used to screen combinatorial libraries synthesized on a solid support. We report here three screens of combinatorial libraries using gel permeation assays. These include a simple enzymatic assay to identify inhibitors of the influenza enzyme neuraminidase, and two more complex assays designed to screen for inhibitors of the interleukin-8 (IL-8)-IL-8 receptor and the urokinase-urokinase receptor interactions, respectively. The IL-8 ligand-receptor assay makes use of IL-8 receptor-expressing cells attached to a membrane, thus enabling washing steps as part of the assay. The urokinase ligand-receptor assay employs an enzyme-linked immunosorbent assay-type format, previously thought to be amenable only to well-based assays. The results of these three screens are reported here, including the discovery of a novel series of acyclic inhibitors of neuraminidase. The development of complex assays in a gel permeation format allows for the routine screening of combinatorially as well as noncombinatorially made compound collections against virtually any kind of target, and is being widely used in our high throughput screening operations.